gsk peptide has been researched along with dicumarol in 1 studies
| Studies (gsk peptide) | Trials (gsk peptide) | Recent Studies (post-2010) (gsk peptide) | Studies (dicumarol) | Trials (dicumarol) | Recent Studies (post-2010) (dicumarol) |
|---|---|---|---|---|---|
| 7 | 1 | 1 | 2,260 | 33 | 110 |
| Protein | Taxonomy | gsk peptide (IC50) | dicumarol (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.0026 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.3 | |
| NAD | Homo sapiens (human) | 0.2585 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 4.426 | |
| Proprotein convertase subtilisin/kexin type 7 | Homo sapiens (human) | 1.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, K; Kenchappa, P; Nandana, S; Singh, G; Yadav, A | 1 |
1 other study(ies) available for gsk peptide and dicumarol
| Article | Year |
|---|---|
Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Antioxidants; Butylated Hydroxyanisole; Caspases; Cell Death; Cell Division; Cell Survival; Chromones; Dicumarol; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Insulin-Like Growth Factor I; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Morpholines; Neuroblastoma; Neurons; Oligopeptides; PC12 Cells; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Time Factors; Transcription Factors; Tumor Necrosis Factor-alpha | 2004 |